A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today shared promising results from the ...
In this excerpt from the new book 'Speak Data,' the Wharton professor and best-selling author shares his thoughts on how we ...
Cordis unveils positive results from SELUTION DeNovo and SELUTION4ISR randomized trials at TCT 2025: Our Bureau, Mumbai ...
Cordis, a global leader in interventional cardiovascular technology, announced the groundbreaking results from the SELUTION ...
The weeks leading up to a major surgery can be a time of uncertainty and worry for patients, many of whom anticipate the need ...
ATLANTA -- Front-of-package food labels that provide an overall rating of product healthfulness were most effective in ...
The Primary Oral Insulin Trial (POInT) investigates whether type 1 diabetes in at-risk children can be prevented through oral ...
NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...
Scientists across all fields make various types of claims about their innovations. Validity tests check whether they deliver ...
New research reveals insomnia's deep links to cardiovascular health, urging us to treat it as a core medical issue, not a ...